デフォルト表紙
市場調査レポート
商品コード
1470300

肺気腫治療薬の世界市場に関する洞察、2030年までの予測

Global Emphysema Treatment Medication Market Insights, Forecast to 2030

出版日: | 発行: QYResearch | ページ情報: 英文 153 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
肺気腫治療薬の世界市場に関する洞察、2030年までの予測
出版日: 2024年04月26日
発行: QYResearch
ページ情報: 英文 153 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、肺気腫治療薬 (Emphysema Treatment Medication) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の肺気腫治療薬の市場規模成長率:タイプ別: 2019 VS 2023 VS 2030
    • Bronchodilators
    • Steroids
    • Others
  • 市場:用途別
    • 世界の肺気腫治療薬の市場シェア:用途別: 2019 VS 2023 VS 2030
    • Hospitals
    • Homecare
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の肺気腫治療薬の市場展望 (2019-2030)
  • 世界の肺気腫治療薬の市場成長トレンド:地域別
    • 世界の肺気腫治療薬 市場規模:地域別: 2019 VS 2023 VS 2030
    • 肺気腫治療薬の市場規模実績:地域別 (2019-2024)
    • 肺気腫治療薬の市場規模予測:地域別 (2025-2030)
  • 肺気腫治療薬 市場動向
    • 肺気腫治療薬 業界動向
    • 肺気腫治療薬 市場の促進要因
    • 肺気腫治療薬 市場の課題
    • 肺気腫治療薬 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界規模の売上高 肺気腫治療薬 :競合別
    • 世界の肺気腫治療薬の収益:企業別 (2019-2024)
    • 世界の肺気腫治療薬の収益シェア:企業別 (2019-2024)
  • 世界の肺気腫治療薬の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 肺気腫治療薬, 売上高ランキング, 2022 VS 2023 VS 2024
  • 世界の肺気腫治療薬 市場集中度
    • 世界の肺気腫治療薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: 肺気腫治療薬の収益 2023
  • 世界の主要企業 肺気腫治療薬 本社 および提供地域
  • 世界の主要企業 肺気腫治療薬, 製品およびアプリケーション
  • 世界の主要企業 肺気腫治療薬, 業界参入時期
  • M&A, 拡張計画

第4章 肺気腫治療薬 内訳データ:タイプ別

  • 世界の肺気腫治療薬の市場規模実績:タイプ別 (2019-2024)
  • 世界の肺気腫治療薬の市場規模予測:タイプ別 (2025-2030)

第5章 肺気腫治療薬 内訳データ:用途別

  • 世界の肺気腫治療薬の市場規模実績:用途別 (2019-2024)
  • 世界の肺気腫治療薬の市場規模予測:用途別 (2025-2030)

第6章 北米

  • 北米の肺気腫治療薬 市場規模 (2019-2030)
  • 北米の肺気腫治療薬 市場規模:タイプ別
    • 北米の肺気腫治療薬 市場規模:タイプ別 (2019-2024)
    • 北米の肺気腫治療薬 市場規模:タイプ別 (2025-2030)
    • 北米の肺気腫治療薬の市場シェア:タイプ別 (2019-2030)
  • 北米の肺気腫治療薬 市場規模:用途別
    • 北米の肺気腫治療薬 市場規模:用途別 (2019-2024)
    • 北米の肺気腫治療薬 市場規模:用途別 (2025-2030)
    • 北米の肺気腫治療薬の市場シェア:用途別 (2019-2030)
  • 北米の肺気腫治療薬 市場規模:国別
    • 北米の肺気腫治療薬 市場規模:国別: 2019 VS 2023 VS 2030
    • 北米の肺気腫治療薬 市場規模:国別 (2019-2024)
    • 北米の肺気腫治療薬 市場 シェア 国別 (2025-2030)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の肺気腫治療薬 市場規模 (2019-2030)
  • 欧州の肺気腫治療薬 市場規模:タイプ別
    • 欧州の肺気腫治療薬 市場規模:タイプ別 (2019-2024)
    • 欧州の肺気腫治療薬 市場規模:タイプ別 (2025-2030)
    • 欧州の肺気腫治療薬の市場シェア:タイプ別 (2019-2030)
  • 欧州の肺気腫治療薬 市場規模:用途別
    • 欧州の肺気腫治療薬 市場規模:用途別 (2019-2024)
    • 欧州の肺気腫治療薬 市場規模:用途別 (2025-2030)
    • 欧州の肺気腫治療薬の市場シェア:用途別 (2019-2030)
  • 欧州の肺気腫治療薬 市場規模:国別
    • 欧州の肺気腫治療薬 市場規模:国別: 2019 VS 2023 VS 2030
    • 欧州の肺気腫治療薬 市場規模:国別 (2019-2024)
    • 欧州の肺気腫治療薬 市場規模:国別 (2025-2030)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の肺気腫治療薬 市場規模 (2019-2030)
  • 中国の肺気腫治療薬 市場規模:タイプ別
    • 中国の肺気腫治療薬 市場規模:タイプ別 (2019-2024)
    • 中国の肺気腫治療薬 市場規模:タイプ別 (2025-2030)
    • 中国の肺気腫治療薬の市場シェア:タイプ別 (2019-2030)
  • 中国の肺気腫治療薬 市場規模:用途別
    • 中国の肺気腫治療薬 市場規模:用途別 (2019-2024)
    • 中国の肺気腫治療薬 市場規模:用途別 (2025-2030)
    • 中国の肺気腫治療薬の市場シェア:用途別 (2019-2030)

第9章 アジア(中国を除く)

  • アジア地域 肺気腫治療薬 市場規模 (2019-2030)
  • アジア地域 肺気腫治療薬 市場規模:タイプ別
    • アジア地域 肺気腫治療薬 市場規模:タイプ別 (2019-2024)
    • アジア地域 肺気腫治療薬 市場規模:タイプ別 (2025-2030)
    • アジア地域 肺気腫治療薬の市場シェア:タイプ別 (2019-2030)
  • アジア地域 肺気腫治療薬 市場規模:用途別
    • アジア地域 肺気腫治療薬 市場規模:用途別 (2019-2024)
    • アジア地域 肺気腫治療薬 市場規模:用途別 (2025-2030)
    • アジア地域 肺気腫治療薬の市場シェア:用途別 (2019-2030)
  • アジア地域 肺気腫治療薬 市場規模:地域別
    • アジア地域 肺気腫治療薬 市場規模:地域別: 2019 VS 2023 VS 2030
    • アジア地域 肺気腫治療薬 市場規模:地域別 (2019-2024)
    • アジア地域 肺気腫治療薬 市場規模:地域別 (2025-2030)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模 (2019-2030)
  • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:タイプ別
    • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:タイプ別 (2019-2024)
    • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:タイプ別 (2025-2030)
    • 中近東・アフリカ・中南米 肺気腫治療薬の市場シェア:タイプ別 (2019-2030)
  • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:用途別
    • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:用途別 (2019-2024)
    • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:用途別 (2025-2030)
    • 中近東・アフリカ・中南米 肺気腫治療薬の市場シェア:用途別 (2019-2030)
  • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:国別
    • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:国別: 2019 VS 2023 VS 2030
    • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:国別 (2019-2024)
    • 中近東・アフリカ・中南米 肺気腫治療薬 市場規模:国別 (2025-2030)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Emphasys Medical
  • Pfizer
  • Uptake Medical
  • Inogen, Inc
  • Viatris Inc
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • AstraZeneca
  • Orion Corporation
  • Teva Pharmaceutical Industries Ltd
  • Verona Pharma Plc
  • GlaxoSmithKline Plc
  • Pulmonx
  • Bioxyne
  • Intrexon
  • Icure Pharmaceuticals
  • Kamada

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

Table 1. Global Emphysema Treatment Medication Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Bronchodilators

Table 3. Key Players of Steroids

Table 4. Key Players of Others

Table 5. Global Emphysema Treatment Medication Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Emphysema Treatment Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Emphysema Treatment Medication Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Emphysema Treatment Medication Market Share by Region (2019-2024)

Table 9. Global Emphysema Treatment Medication Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Emphysema Treatment Medication Market Share by Region (2025-2030)

Table 11. Emphysema Treatment Medication Market Trends

Table 12. Emphysema Treatment Medication Market Drivers

Table 13. Emphysema Treatment Medication Market Challenges

Table 14. Emphysema Treatment Medication Market Restraints

Table 15. Global Emphysema Treatment Medication Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Emphysema Treatment Medication Market Share by Players (2019-2024)

Table 17. Global Top Emphysema Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment Medication as of 2023)

Table 18. Global Emphysema Treatment Medication Industry Ranking 2022 VS 2023

Table 19. Global 5 Largest Players Market Share by Emphysema Treatment Medication Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Emphysema Treatment Medication, Headquarters and Area Served

Table 21. Global Key Players of Emphysema Treatment Medication, Product and Application

Table 22. Global Key Players of Emphysema Treatment Medication, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Emphysema Treatment Medication Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Emphysema Treatment Medication Revenue Market Share by Type (2019-2024)

Table 26. Global Emphysema Treatment Medication Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Emphysema Treatment Medication Revenue Market Share by Type (2025-2030)

Table 28. Global Emphysema Treatment Medication Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Emphysema Treatment Medication Revenue Market Share by Application (2019-2024)

Table 30. Global Emphysema Treatment Medication Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Emphysema Treatment Medication Revenue Market Share by Application (2025-2030)

Table 32. North America Emphysema Treatment Medication Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Emphysema Treatment Medication Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Emphysema Treatment Medication Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Emphysema Treatment Medication Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Emphysema Treatment Medication Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Emphysema Treatment Medication Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Emphysema Treatment Medication Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Emphysema Treatment Medication Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Emphysema Treatment Medication Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Emphysema Treatment Medication Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Emphysema Treatment Medication Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Emphysema Treatment Medication Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Emphysema Treatment Medication Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Emphysema Treatment Medication Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Emphysema Treatment Medication Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Emphysema Treatment Medication Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Emphysema Treatment Medication Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Emphysema Treatment Medication Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Emphysema Treatment Medication Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Emphysema Treatment Medication Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Emphysema Treatment Medication Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Emphysema Treatment Medication Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Emphysema Treatment Medication Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Emphysema Treatment Medication Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Emphysema Treatment Medication Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Emphysema Treatment Medication Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Country (2025-2030) & (US$ Million)

Table 64. Emphasys Medical Company Details

Table 65. Emphasys Medical Business Overview

Table 66. Emphasys Medical Emphysema Treatment Medication Product

Table 67. Emphasys Medical Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 68. Emphasys Medical Recent Development

Table 69. Pfizer Company Details

Table 70. Pfizer Business Overview

Table 71. Pfizer Emphysema Treatment Medication Product

Table 72. Pfizer Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 73. Pfizer Recent Development

Table 74. Uptake Medical Company Details

Table 75. Uptake Medical Business Overview

Table 76. Uptake Medical Emphysema Treatment Medication Product

Table 77. Uptake Medical Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 78. Uptake Medical Recent Development

Table 79. Inogen, Inc Company Details

Table 80. Inogen, Inc Business Overview

Table 81. Inogen, Inc Emphysema Treatment Medication Product

Table 82. Inogen, Inc Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 83. Inogen, Inc Recent Development

Table 84. Viatris Inc Company Details

Table 85. Viatris Inc Business Overview

Table 86. Viatris Inc Emphysema Treatment Medication Product

Table 87. Viatris Inc Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 88. Viatris Inc Recent Development

Table 89. Boehringer Ingelheim International GmbH Company Details

Table 90. Boehringer Ingelheim International GmbH Business Overview

Table 91. Boehringer Ingelheim International GmbH Emphysema Treatment Medication Product

Table 92. Boehringer Ingelheim International GmbH Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 93. Boehringer Ingelheim International GmbH Recent Development

Table 94. Novartis AG Company Details

Table 95. Novartis AG Business Overview

Table 96. Novartis AG Emphysema Treatment Medication Product

Table 97. Novartis AG Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 98. Novartis AG Recent Development

Table 99. AstraZeneca Company Details

Table 100. AstraZeneca Business Overview

Table 101. AstraZeneca Emphysema Treatment Medication Product

Table 102. AstraZeneca Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 103. AstraZeneca Recent Development

Table 104. Orion Corporation Company Details

Table 105. Orion Corporation Business Overview

Table 106. Orion Corporation Emphysema Treatment Medication Product

Table 107. Orion Corporation Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 108. Orion Corporation Recent Development

Table 109. Teva Pharmaceutical Industries Ltd Company Details

Table 110. Teva Pharmaceutical Industries Ltd Business Overview

Table 111. Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Product

Table 112. Teva Pharmaceutical Industries Ltd Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 113. Teva Pharmaceutical Industries Ltd Recent Development

Table 114. Verona Pharma Plc Company Details

Table 115. Verona Pharma Plc Business Overview

Table 116. Verona Pharma Plc Emphysema Treatment Medication Product

Table 117. Verona Pharma Plc Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 118. Verona Pharma Plc Recent Development

Table 119. GlaxoSmithKline Plc Company Details

Table 120. GlaxoSmithKline Plc Business Overview

Table 121. GlaxoSmithKline Plc Emphysema Treatment Medication Product

Table 122. GlaxoSmithKline Plc Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 123. GlaxoSmithKline Plc Recent Development

Table 124. Pulmonx Company Details

Table 125. Pulmonx Business Overview

Table 126. Pulmonx Emphysema Treatment Medication Product

Table 127. Pulmonx Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 128. Pulmonx Recent Development

Table 129. Bioxyne Company Details

Table 130. Bioxyne Business Overview

Table 131. Bioxyne Emphysema Treatment Medication Product

Table 132. Bioxyne Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 133. Bioxyne Recent Development

Table 134. Intrexon Company Details

Table 135. Intrexon Business Overview

Table 136. Intrexon Emphysema Treatment Medication Product

Table 137. Intrexon Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 138. Intrexon Recent Development

Table 139. Icure Pharmaceuticals Company Details

Table 140. Icure Pharmaceuticals Business Overview

Table 141. Icure Pharmaceuticals Emphysema Treatment Medication Product

Table 142. Icure Pharmaceuticals Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 143. Icure Pharmaceuticals Recent Development

Table 144. Kamada Company Details

Table 145. Kamada Business Overview

Table 146. Kamada Emphysema Treatment Medication Product

Table 147. Kamada Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)

Table 148. Kamada Recent Development

Table 149. Research Programs/Design for This Report

Table 150. Key Data Information from Secondary Sources

Table 151. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Emphysema Treatment Medication Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Emphysema Treatment Medication Market Share by Type: 2023 VS 2030

Figure 3. Bronchodilators Features

Figure 4. Steroids Features

Figure 5. Others Features

Figure 6. Global Emphysema Treatment Medication Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Emphysema Treatment Medication Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Homecare Case Studies

Figure 10. Others Case Studies

Figure 11. Emphysema Treatment Medication Report Years Considered

Figure 12. Global Emphysema Treatment Medication Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Emphysema Treatment Medication Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Emphysema Treatment Medication Market Share by Region: 2023 VS 2030

Figure 15. Global Emphysema Treatment Medication Market Share by Players in 2023

Figure 16. Global Top Emphysema Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment Medication as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Emphysema Treatment Medication Revenue in 2023

Figure 18. North America Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Emphysema Treatment Medication Market Share by Type (2019-2030)

Figure 20. North America Emphysema Treatment Medication Market Share by Application (2019-2030)

Figure 21. North America Emphysema Treatment Medication Market Share by Country (2019-2030)

Figure 22. United States Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Emphysema Treatment Medication Market Share by Type (2019-2030)

Figure 26. Europe Emphysema Treatment Medication Market Share by Application (2019-2030)

Figure 27. Europe Emphysema Treatment Medication Market Share by Country (2019-2030)

Figure 28. Germany Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Emphysema Treatment Medication Market Share by Type (2019-2030)

Figure 36. China Emphysema Treatment Medication Market Share by Application (2019-2030)

Figure 37. Asia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia Emphysema Treatment Medication Market Share by Type (2019-2030)

Figure 39. Asia Emphysema Treatment Medication Market Share by Application (2019-2030)

Figure 40. Asia Emphysema Treatment Medication Market Share by Region (2019-2030)

Figure 41. Japan Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Emphysema Treatment Medication Market Share by Country (2019-2030)

Figure 51. Brazil Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Emphasys Medical Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 58. Pfizer Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 59. Uptake Medical Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 60. Inogen, Inc Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 61. Viatris Inc Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 62. Boehringer Ingelheim International GmbH Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 63. Novartis AG Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 64. AstraZeneca Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 65. Orion Corporation Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 66. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 67. Verona Pharma Plc Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 68. GlaxoSmithKline Plc Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 69. Pulmonx Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 70. Bioxyne Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 71. Intrexon Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 72. Icure Pharmaceuticals Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 73. Kamada Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

目次

This research report focuses on the Emphysema Treatment Medication Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Emphysema Treatment Medication Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 Bronchodilators
    • 1.2.3 Steroids
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Emphysema Treatment Medication Market Share by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Hospitals
    • 1.3.3 Homecare
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Emphysema Treatment Medication Market Perspective (2019-2030)
  • 2.2 Global Emphysema Treatment Medication Growth Trends by Region
    • 2.2.1 Global Emphysema Treatment Medication Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Emphysema Treatment Medication Historic Market Size by Region (2019-2024)
    • 2.2.3 Emphysema Treatment Medication Forecasted Market Size by Region (2025-2030)
  • 2.3 Emphysema Treatment Medication Market Dynamics
    • 2.3.1 Emphysema Treatment Medication Industry Trends
    • 2.3.2 Emphysema Treatment Medication Market Drivers
    • 2.3.3 Emphysema Treatment Medication Market Challenges
    • 2.3.4 Emphysema Treatment Medication Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Emphysema Treatment Medication by Players
    • 3.1.1 Global Emphysema Treatment Medication Revenue by Players (2019-2024)
    • 3.1.2 Global Emphysema Treatment Medication Revenue Market Share by Players (2019-2024)
  • 3.2 Global Emphysema Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Emphysema Treatment Medication, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Emphysema Treatment Medication Market Concentration Ratio
    • 3.4.1 Global Emphysema Treatment Medication Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Emphysema Treatment Medication Revenue in 2023
  • 3.5 Global Key Players of Emphysema Treatment Medication Head office and Area Served
  • 3.6 Global Key Players of Emphysema Treatment Medication, Product and Application
  • 3.7 Global Key Players of Emphysema Treatment Medication, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Emphysema Treatment Medication Breakdown Data by Type

  • 4.1 Global Emphysema Treatment Medication Historic Market Size by Type (2019-2024)
  • 4.2 Global Emphysema Treatment Medication Forecasted Market Size by Type (2025-2030)

5 Emphysema Treatment Medication Breakdown Data by Application

  • 5.1 Global Emphysema Treatment Medication Historic Market Size by Application (2019-2024)
  • 5.2 Global Emphysema Treatment Medication Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Emphysema Treatment Medication Market Size (2019-2030)
  • 6.2 North America Emphysema Treatment Medication Market Size by Type
    • 6.2.1 North America Emphysema Treatment Medication Market Size by Type (2019-2024)
    • 6.2.2 North America Emphysema Treatment Medication Market Size by Type (2025-2030)
    • 6.2.3 North America Emphysema Treatment Medication Market Share by Type (2019-2030)
  • 6.3 North America Emphysema Treatment Medication Market Size by Application
    • 6.3.1 North America Emphysema Treatment Medication Market Size by Application (2019-2024)
    • 6.3.2 North America Emphysema Treatment Medication Market Size by Application (2025-2030)
    • 6.3.3 North America Emphysema Treatment Medication Market Share by Application (2019-2030)
  • 6.4 North America Emphysema Treatment Medication Market Size by Country
    • 6.4.1 North America Emphysema Treatment Medication Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Emphysema Treatment Medication Market Size by Country (2019-2024)
    • 6.4.3 North America Emphysema Treatment Medication Market Share by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Emphysema Treatment Medication Market Size (2019-2030)
  • 7.2 Europe Emphysema Treatment Medication Market Size by Type
    • 7.2.1 Europe Emphysema Treatment Medication Market Size by Type (2019-2024)
    • 7.2.2 Europe Emphysema Treatment Medication Market Size by Type (2025-2030)
    • 7.2.3 Europe Emphysema Treatment Medication Market Share by Type (2019-2030)
  • 7.3 Europe Emphysema Treatment Medication Market Size by Application
    • 7.3.1 Europe Emphysema Treatment Medication Market Size by Application (2019-2024)
    • 7.3.2 Europe Emphysema Treatment Medication Market Size by Application (2025-2030)
    • 7.3.3 Europe Emphysema Treatment Medication Market Share by Application (2019-2030)
  • 7.4 Europe Emphysema Treatment Medication Market Size by Country
    • 7.4.1 Europe Emphysema Treatment Medication Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Emphysema Treatment Medication Market Size by Country (2019-2024)
    • 7.4.3 Europe Emphysema Treatment Medication Market Size by Country (2025-2030)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia
    • 7.4.9 Nordic Countries

8 China

  • 8.1 China Emphysema Treatment Medication Market Size (2019-2030)
  • 8.2 China Emphysema Treatment Medication Market Size by Type
    • 8.2.1 China Emphysema Treatment Medication Market Size by Type (2019-2024)
    • 8.2.2 China Emphysema Treatment Medication Market Size by Type (2025-2030)
    • 8.2.3 China Emphysema Treatment Medication Market Share by Type (2019-2030)
  • 8.3 China Emphysema Treatment Medication Market Size by Application
    • 8.3.1 China Emphysema Treatment Medication Market Size by Application (2019-2024)
    • 8.3.2 China Emphysema Treatment Medication Market Size by Application (2025-2030)
    • 8.3.3 China Emphysema Treatment Medication Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Emphysema Treatment Medication Market Size (2019-2030)
  • 9.2 Asia Emphysema Treatment Medication Market Size by Type
    • 9.2.1 Asia Emphysema Treatment Medication Market Size by Type (2019-2024)
    • 9.2.2 Asia Emphysema Treatment Medication Market Size by Type (2025-2030)
    • 9.2.3 Asia Emphysema Treatment Medication Market Share by Type (2019-2030)
  • 9.3 Asia Emphysema Treatment Medication Market Size by Application
    • 9.3.1 Asia Emphysema Treatment Medication Market Size by Application (2019-2024)
    • 9.3.2 Asia Emphysema Treatment Medication Market Size by Application (2025-2030)
    • 9.3.3 Asia Emphysema Treatment Medication Market Share by Application (2019-2030)
  • 9.4 Asia Emphysema Treatment Medication Market Size by Region
    • 9.4.1 Asia Emphysema Treatment Medication Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Emphysema Treatment Medication Market Size by Region (2019-2024)
    • 9.4.3 Asia Emphysema Treatment Medication Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Emphysema Treatment Medication Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Emphasys Medical
    • 11.1.1 Emphasys Medical Company Details
    • 11.1.2 Emphasys Medical Business Overview
    • 11.1.3 Emphasys Medical Emphysema Treatment Medication Introduction
    • 11.1.4 Emphasys Medical Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.1.5 Emphasys Medical Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Emphysema Treatment Medication Introduction
    • 11.2.4 Pfizer Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.2.5 Pfizer Recent Development
  • 11.3 Uptake Medical
    • 11.3.1 Uptake Medical Company Details
    • 11.3.2 Uptake Medical Business Overview
    • 11.3.3 Uptake Medical Emphysema Treatment Medication Introduction
    • 11.3.4 Uptake Medical Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.3.5 Uptake Medical Recent Development
  • 11.4 Inogen, Inc
    • 11.4.1 Inogen, Inc Company Details
    • 11.4.2 Inogen, Inc Business Overview
    • 11.4.3 Inogen, Inc Emphysema Treatment Medication Introduction
    • 11.4.4 Inogen, Inc Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.4.5 Inogen, Inc Recent Development
  • 11.5 Viatris Inc
    • 11.5.1 Viatris Inc Company Details
    • 11.5.2 Viatris Inc Business Overview
    • 11.5.3 Viatris Inc Emphysema Treatment Medication Introduction
    • 11.5.4 Viatris Inc Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.5.5 Viatris Inc Recent Development
  • 11.6 Boehringer Ingelheim International GmbH
    • 11.6.1 Boehringer Ingelheim International GmbH Company Details
    • 11.6.2 Boehringer Ingelheim International GmbH Business Overview
    • 11.6.3 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Introduction
    • 11.6.4 Boehringer Ingelheim International GmbH Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.6.5 Boehringer Ingelheim International GmbH Recent Development
  • 11.7 Novartis AG
    • 11.7.1 Novartis AG Company Details
    • 11.7.2 Novartis AG Business Overview
    • 11.7.3 Novartis AG Emphysema Treatment Medication Introduction
    • 11.7.4 Novartis AG Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.7.5 Novartis AG Recent Development
  • 11.8 AstraZeneca
    • 11.8.1 AstraZeneca Company Details
    • 11.8.2 AstraZeneca Business Overview
    • 11.8.3 AstraZeneca Emphysema Treatment Medication Introduction
    • 11.8.4 AstraZeneca Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.8.5 AstraZeneca Recent Development
  • 11.9 Orion Corporation
    • 11.9.1 Orion Corporation Company Details
    • 11.9.2 Orion Corporation Business Overview
    • 11.9.3 Orion Corporation Emphysema Treatment Medication Introduction
    • 11.9.4 Orion Corporation Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.9.5 Orion Corporation Recent Development
  • 11.10 Teva Pharmaceutical Industries Ltd
    • 11.10.1 Teva Pharmaceutical Industries Ltd Company Details
    • 11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
    • 11.10.3 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Introduction
    • 11.10.4 Teva Pharmaceutical Industries Ltd Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.10.5 Teva Pharmaceutical Industries Ltd Recent Development
  • 11.11 Verona Pharma Plc
    • 11.11.1 Verona Pharma Plc Company Details
    • 11.11.2 Verona Pharma Plc Business Overview
    • 11.11.3 Verona Pharma Plc Emphysema Treatment Medication Introduction
    • 11.11.4 Verona Pharma Plc Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.11.5 Verona Pharma Plc Recent Development
  • 11.12 GlaxoSmithKline Plc
    • 11.12.1 GlaxoSmithKline Plc Company Details
    • 11.12.2 GlaxoSmithKline Plc Business Overview
    • 11.12.3 GlaxoSmithKline Plc Emphysema Treatment Medication Introduction
    • 11.12.4 GlaxoSmithKline Plc Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.12.5 GlaxoSmithKline Plc Recent Development
  • 11.13 Pulmonx
    • 11.13.1 Pulmonx Company Details
    • 11.13.2 Pulmonx Business Overview
    • 11.13.3 Pulmonx Emphysema Treatment Medication Introduction
    • 11.13.4 Pulmonx Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.13.5 Pulmonx Recent Development
  • 11.14 Bioxyne
    • 11.14.1 Bioxyne Company Details
    • 11.14.2 Bioxyne Business Overview
    • 11.14.3 Bioxyne Emphysema Treatment Medication Introduction
    • 11.14.4 Bioxyne Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.14.5 Bioxyne Recent Development
  • 11.15 Intrexon
    • 11.15.1 Intrexon Company Details
    • 11.15.2 Intrexon Business Overview
    • 11.15.3 Intrexon Emphysema Treatment Medication Introduction
    • 11.15.4 Intrexon Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.15.5 Intrexon Recent Development
  • 11.16 Icure Pharmaceuticals
    • 11.16.1 Icure Pharmaceuticals Company Details
    • 11.16.2 Icure Pharmaceuticals Business Overview
    • 11.16.3 Icure Pharmaceuticals Emphysema Treatment Medication Introduction
    • 11.16.4 Icure Pharmaceuticals Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.16.5 Icure Pharmaceuticals Recent Development
  • 11.17 Kamada
    • 11.17.1 Kamada Company Details
    • 11.17.2 Kamada Business Overview
    • 11.17.3 Kamada Emphysema Treatment Medication Introduction
    • 11.17.4 Kamada Revenue in Emphysema Treatment Medication Business (2019-2024)
    • 11.17.5 Kamada Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer